Bipolar Disorder Trial, Recruiting NCT06524505 Sponsor: Tianjin Anding Hospital Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06524505
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of bipolar depression
  • People between 18 and 65 years of age
  • People whose depression symptoms are rated as moderately severe or above on a standard assessment scale (a score of 17 or higher on the 17-item Hamilton Depression Rating Scale)
  • People who have been on a stable medication plan for at least 4 weeks before the treatment phase begins
  • People who previously took antidepressant medications and have completed at least a 4-week break from those medications before being reassessed

Who may not be able to join:

  • People who have ever been diagnosed with another psychiatric condition, a neurological disease, or who have had a severe brain injury
  • People who have received certain brain stimulation treatments (such as electroconvulsive therapy, rTMS, or related procedures) within the past 3 months
  • People who have conditions that make magnetic stimulation unsafe, such as epilepsy, heart or cardiovascular disorders, or metal implants in the head
  • People who are showing signs of elevated or manic mood at the start of the trial, or who score above 12 on a standard mania rating scale
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 022 88188006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tianjin Anding Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The change over time in the score of Hamilton Depression Rating Scale (HDRS-17).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov